from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2210c/ilvE

LFCtreatmentdescriptionclass of inhibitor

-0.839

Amikacinug/mL Amikacintranslation

-0.553

Cap5-10ug/mL Capreomycintranslation

0.147

Rox10-50 ug/mL Roxithromycintranslation

0.182

SM2-5 ug/mL Streptomycintranslation

-0.530

Tet5-10 ug/mL Tetracyclinetranslation

-0.149

Rif0.2-5ug/mL Rifampicintranscription

-0.963

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.253

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.027

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.721

CPZ10-50 ug/mL Chlorpromazinerespiration

0.387

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.263

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.506

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.098

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.763

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.422

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.237

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.426

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.970

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.813

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.379

KCN5-20 ug/mL Potassium cyaniderespiration

0.705

NaN30.2-2 mM Sodium aziderespiration

-0.294

Nigericin50 uM Nigericinrespiration

0.056

TRC10-150 ug/mL Triclosanrespiration

0.605

TRZ10-25 ug/mL Thioridazinerespiration

-1.117

Valinomycin0.5-10 uM Valinomycinrespiration

0.405

ZnSO42 mM ZnSO4respiration

-0.156

menadione6-10 ug/mL Menadionerespiration

-0.331

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.744

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.350

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.157

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.007

NRP_1Non-replicating persistence stage 1dosRassociated

-0.021

Amp0.2mg/mL AmpicillincellWall

-0.062

Cephalexin20-100 ug/mL CephalexincellWall

-0.512

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.638

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.649

EMB10-20 ug/mL EthambutolcellWall

0.028

Eta12-40 ug/mL EthionamidecellWall

-0.219

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.159

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.472

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.705

BZA0.12 mg/mL BenzamidearomaticAmides

0.896

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.554

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.062

H2O24 mM hydrogen peroxideDNAdamaging

-1.103

Levo10 ug/mL LevofloxacinDNAdamaging

0.107

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.263

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.140

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.319

UVUV-irradiationDNAdamaging

-0.025

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.630

Antimycin12.5-50 ug/mL Antimycin A?

0.054

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.707

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.029

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.941

PA8240.2-2 ug/mL PA-824?

1.663

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.423

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.447

Verapamil50 uM Verapamil?

-0.754

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.469

methoxatin10-20 ug/mL Methoxatin?